A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations
Villaruz, L.C., Wang, X., Bertino, E.M., Gu, L., Antonia, S.J., Burns, T.F., Clarke, J., Crawford, J., Evans, T.L., Friedland, D.M., Otterson, G.A., Ready, N.E., Wozniak, A.J., Stinchcombe, T.E.
Published in ESMO open (01.04.2023)
Published in ESMO open (01.04.2023)
Get full text
Journal Article
Immune related adverse events across cancer types: Incidence, risk factors and survival
Owen, D.H., Burkart, J., Patel, S., Wei, L., Tinoco, G., Liebner, D., He, K., Shields, P.G., Bertino, E.M., Presley, C.J., Johns, A., Folefac, E., Olencki, T., Carbone, D.P., Verschraegen, C., Otterson, G.A., Kendra, K.L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A randomized phase II trial of erlotinib or erlotinib and bevacizumab in patients with advanced EGFR mutant non-small cell lung cancer (NSCLC)
Stinchcombe, T.E., Janne, P.A., Wang, X., Bertino, E.M., Weiss, J.M., Bazhenova, L., Gu, L., Lau, C.J., Paweletz, C.P., Jaslowski, A.J., Gerstner, G.J., Baggstrom, M.Q., Graziano, S.L., Bearden, J., Vokes, E.E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A Phase II Trial of Primary Tumor SBRT Boost Prior to Concurrent Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
Williams, T.M., Welliver, M.X., Brownstein, J.M., Otterson, G., Owen, D., Pan, J., Haglund, K.E., Shields, P.G., Bertino, E.M., Presley, C., He, K., Miller, E.D., Yang, X., Knopp, M., Essan, J.Kousou, McElroy, S., Carbone, D.P., Bazan, J.G.
Published in International journal of radiation oncology, biology, physics (01.11.2021)
Published in International journal of radiation oncology, biology, physics (01.11.2021)
Get full text
Journal Article
1444PA randomized phase II trial of erlotinib or erlotinib and bevacizumab in patients with advanced EGFR mutant non-small cell lung cancer (NSCLC)
Stinchcombe, T E, Janne, P A, Wang, X, Bertino, E M, Weiss, J M, Bazhenova, L, Gu, L, Lau, C J, Paweletz, C P, Jaslowski, A J, Gerstner, G J, Baggstrom, M Q, Graziano, S L, Bearden, J, Vokes, E E
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1772PImmune related adverse events across cancer types: Incidence, risk factors and survival
Owen, D H, Burkart, J, Patel, S, Wei, L, Tinoco, G, Liebner, D, He, K, Shields, P G, Bertino, E M, Presley, C J, Johns, A, Folefac, E, Olencki, T, Carbone, D P, Verschraegen, C, Otterson, G A, Kendra, K L
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1478OResults of the ASCEND-7 phase II study evaluating ALK inhibitor (ALKi) ceritinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) metastatic to the brain
Chow, L Q, Barlesi, F, Bertino, E M, van den Bent, M J, Wakelee, H, Wen, P Y, Chiu, C-H, Orlov, S, Majem, M, Chiari, R, McKeage, M, Yu, C-J, Hurtado, F K, Arratia, P Cazorla, Song, Y, Branle, F, Shi, M, Kim, D-W
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
390OEfficacy and safety of ceritinib in ALK-positive non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): Results from the phase II, ASCEND-7 study
Barlesi, F, Kim, D -W, Bertino, E M, van den Bent, M J, Wakelee, H, Wen, P Y, Garrido Lopez, P, Orlov, S, Majem, M, McKeage, M, Yu, C -J, Hurtado, F K, Cazorla Arratia, P, Song, Y, Branle, F, Shi, M, Chow, L Q
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Final Results of a Phase 3 Trial of Celecoxib (C) in Addition to Standard Chemotherapy for Advanced Non–Small Cell Lung Cancer With COX- 2 Overexpression: CALGB 30801 (Alliance)
Edelman, M.J, Wang, X, Hodgson, L, Cheney, R.T, Baggstrom, M.Q, Sachdev, T, Gajra, A, Bertino, E.M, Reckamp, K.L, Molina, J, Schiller, J, Mitchell-Edwards, K, Friedman, P, Ritter, J, Milne, G, Stinchcombe, T.E, Hahn, O, Vokes, E.E
Published in International journal of radiation oncology, biology, physics (01.05.2017)
Published in International journal of radiation oncology, biology, physics (01.05.2017)
Get full text
Journal Article
EML4-ALK in NSCLC: The OSU Experience
Bertino, E. M., Zhao, W., Villalona-Calero, M. A., Abdel Karim, N. F., Shilo, K., Otterson, G. A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Phase II trial of nab-paclitaxel plus carboplatin for advanced NSCLC in patients at risk of bleeding from VEGF-directed therapies
Bertino, E. M., Otterson, G. A., Villalona-Calero, M. A., Nana-Sinkam, S. P., Ghany, A. M., Donthireddy, K. R., Abdel Karim, N. F., Cantrell, S., Phillips, G. S.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Patterning porous matrices and planar substrates with quantum dots
BERTINO, M. F, GADIPALLI, R. R, MARTIN, L. A, STORY, J. G, HECKMAN, B, GUHA, S, LEVENTIS, N
Published in Journal of sol-gel science and technology (01.09.2006)
Published in Journal of sol-gel science and technology (01.09.2006)
Get full text
Journal Article
Practice Guideline for the Performance of Physiologic Evaluation of Extremity Arteries
Bertino, Raymond E., MD, Grassi, Clement J., MD, Bluth, Edward I., MD, Cardella, John F., MD, Frates, Mary, MD, Gooding, Gretchen A., MD, Needleman, Laurence, MD, Pellerito, John S., MD, Rumack, Carol M., MD, Sacks, David, MD
Published in Journal of vascular and interventional radiology (01.10.2007)
Published in Journal of vascular and interventional radiology (01.10.2007)
Get full text
Journal Article